Sensorineural deafness: An uncommon irreversible adverse effect of bortezomib.

Anoop, Parameswaran; Patil, Channappa N; Joshi, Vaishnavi S; Maurya, Poonam; Hosamani, Pradeep

Anoop, Parameswaran; Patil, Channappa N; Joshi, Vaishnavi S; Maurya, Poonam; Hosamani, Pradeep.

Afiliación

Anoop P; Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
Patil CN; Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
Joshi VS; Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
Maurya P; Department of Hemato-Oncology, Apollo Hospitals, Bengaluru, Karnataka, India.
Hosamani P; Department of ENT, Apollo Hospitals, Bengaluru, Karnataka, India.

Indian J Cancer ; 53(3): 459, 2016.

Article en En | MEDLINE | ID: mdl-28244485

Asunto(s)

Antineoplásicos/efectos adversos; Bortezomib/efectos adversos; Pérdida Auditiva Sensorineural/inducido químicamente; Antineoplásicos/uso terapéutico; Bortezomib/uso terapéutico; Femenino; Humanos; Persona de Mediana Edad; Mieloma Múltiple/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bortezomib / Pérdida Auditiva Sensorineural / Antineoplásicos Límite: Female / Humans / Middle aged Idioma: En Revista: Indian J Cancer Año: 2016 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google